BACKGROUND:Increased blood pressure (BP) in type 2 diabetes (T2DM) markedly increases cardiovascular disease morbidity and mortality risk compared to having increased BP alone. OBJECTIVE: To investigate whether exercise reduces suboptimal levels of untreated suboptimal BP or treated hypertension. DESIGN: Prospective, randomized controlled trial for 6 months. SETTING: Single center in Baltimore, MD, USA. PATIENTS: 140 participants with T2DM not requiring insulin and untreated SBP of 120-159 or DBP of 85-99 mmHg, or, if being treated for hypertension, any SBP <159 mmHg or DBP<99 mmHg; 114 completed the study. INTERVENTION: Supervised exercise, 3 times per week for 6 months compared with general advice about physical activity. MEASUREMENTS: Resting SBP and DBP (primary outcome); diabetes status, arterial stiffness assessed as carotid-femoral pulse-wave velocity (PWV), body composition and fitness (secondary outcomes). RESULTS: Overall baseline BP was 126.8 ± 13.5 / 71.7 ± 9.0 mmHg, with no group differences. At 6 months, BP was unchanged from baseline in either group, BP 125.8 ± 13.2 / 70.7 ± 8.8 mmHg in controls; and 126.0 ± 14.2 / 70.3 ± 9.0 mmHg in exercisers, despite attaining a training effects as evidenced by increased aerobic and strength fitness and lean mass and reduced fat mass (all p<0.05), Overall baseline PWV was 959.9 ± 333.1 cm/s, with no group difference. At 6-months, PWV did not change and was not different between group; exercisers, 923.7 ± 319.8 cm/s, 905.5 ± 344.7, controls. LIMITATIONS: A completion rate of 81 %. CONCLUSIONS: Though exercisers improve fitness and body composition, there were no reductions in BP. The lack of change in arterial stiffness suggests a resistance to exercise-induced BP reduction in persons with T2DM.
RCT Entities:
BACKGROUND: Increased blood pressure (BP) in type 2 diabetes (T2DM) markedly increases cardiovascular disease morbidity and mortality risk compared to having increased BP alone. OBJECTIVE: To investigate whether exercise reduces suboptimal levels of untreated suboptimal BP or treated hypertension. DESIGN: Prospective, randomized controlled trial for 6 months. SETTING: Single center in Baltimore, MD, USA. PATIENTS: 140 participants with T2DM not requiring insulin and untreated SBP of 120-159 or DBP of 85-99 mmHg, or, if being treated for hypertension, any SBP <159 mmHg or DBP<99 mmHg; 114 completed the study. INTERVENTION: Supervised exercise, 3 times per week for 6 months compared with general advice about physical activity. MEASUREMENTS: Resting SBP and DBP (primary outcome); diabetes status, arterial stiffness assessed as carotid-femoral pulse-wave velocity (PWV), body composition and fitness (secondary outcomes). RESULTS: Overall baseline BP was 126.8 ± 13.5 / 71.7 ± 9.0 mmHg, with no group differences. At 6 months, BP was unchanged from baseline in either group, BP 125.8 ± 13.2 / 70.7 ± 8.8 mmHg in controls; and 126.0 ± 14.2 / 70.3 ± 9.0 mmHg in exercisers, despite attaining a training effects as evidenced by increased aerobic and strength fitness and lean mass and reduced fat mass (all p<0.05), Overall baseline PWV was 959.9 ± 333.1 cm/s, with no group difference. At 6-months, PWV did not change and was not different between group; exercisers, 923.7 ± 319.8 cm/s, 905.5 ± 344.7, controls. LIMITATIONS: A completion rate of 81 %. CONCLUSIONS: Though exercisers improve fitness and body composition, there were no reductions in BP. The lack of change in arterial stiffness suggests a resistance to exercise-induced BP reduction in persons with T2DM.
Authors: I Giannopoulou; L L Ploutz-Snyder; R Carhart; R S Weinstock; B Fernhall; S Goulopoulou; J A Kanaley Journal: J Clin Endocrinol Metab Date: 2004-12-14 Impact factor: 5.958
Authors: R R Pate; M Pratt; S N Blair; W L Haskell; C A Macera; C Bouchard; D Buchner; W Ettinger; G W Heath; A C King Journal: JAMA Date: 1995-02-01 Impact factor: 56.272
Authors: A Mourier; J F Gautier; E De Kerviler; A X Bigard; J M Villette; J P Garnier; A Duvallet; C Y Guezennec; G Cathelineau Journal: Diabetes Care Date: 1997-03 Impact factor: 19.112
Authors: Kerry J Stewart; Anita C Bacher; Katherine L Turner; Jerome L Fleg; Paul S Hees; Edward P Shapiro; Matthew Tayback; Pamela Ouyang Journal: Arch Intern Med Date: 2005-04-11
Authors: Ronald J Sigal; Glen P Kenny; Normand G Boulé; George A Wells; Denis Prud'homme; Michelle Fortier; Robert D Reid; Heather Tulloch; Douglas Coyle; Penny Phillips; Alison Jennings; James Jaffey Journal: Ann Intern Med Date: 2007-09-18 Impact factor: 25.391
Authors: Linda S Pescatello; Barry A Franklin; Robert Fagard; William B Farquhar; George A Kelley; Chester A Ray Journal: Med Sci Sports Exerc Date: 2004-03 Impact factor: 5.411
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: João E Dos Santos Araujo; Fabrício Nunes Macedo; André Sales Barreto; Márcio R Viana Dos Santos; Angelo R Antoniolli; Lucindo J Quintans-Junior Journal: Rev Diabet Stud Date: 2019-04-19
Authors: David A Donley; Sara B Fournier; Brian L Reger; Evan DeVallance; Daniel E Bonner; I Mark Olfert; Jefferson C Frisbee; Paul D Chantler Journal: J Appl Physiol (1985) Date: 2014-04-17
Authors: Swaytha V Yalamanchi; Kerry J Stewart; Nan Ji; Sherita H Golden; Adrian Dobs; Diane M Becker; Dhananjay Vaidya; Brian G Kral; Rita R Kalyani Journal: Diabetes Res Clin Pract Date: 2016-10-10 Impact factor: 5.602
Authors: Franciele R Figueira; Daniel Umpierre; Felipe V Cureau; Alessandra T N Zucatti; Mériane B Dalzochio; Cristiane B Leitão; Beatriz D Schaan Journal: Sports Med Date: 2014-11 Impact factor: 11.136